Pioglitazone Improves Diabetic Dyslipidaemia in Patients with Type 2 Diabetes Mellitus with or without Lipid-Lowering Therapy

Author： Schöfl Christof  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.25, Iss.5, 2005-01, pp. : 341-345

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pioglitazone improves lipid profiles in type 2 diabetes

By  

Inpharma, Vol. 1, Iss. 1243, 2000-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Pioglitazone is Effective Therapy for Elderly Patients with Type 2 Diabetes Mellitus

By Rajagopalan R.   Perez A.   Ye Z.   Khan M.   Murray F.T.  

Drugs & Aging, Vol. 21, Iss. 4, 2004-01 ,pp. : 259-271

Adis International

Access to resources Recommend Favorite

Consider lipid-lowering therapy for patients with diabetes and hyperlipidaemia

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 283, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Lipid-lowering therapy in diabetes

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 342, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Comparison of the Effects of Policosanol and Atorvastatin on Lipid Profile and Platelet Aggregation in Patients with Dyslipidaemia and Type 2 Diabetes Mellitus

By Castaño G.  

Clinical Drug Investigation, Vol. 23, Iss. 10, 2003-01 ,pp. : 639-650

Adis International

Access to resources Recommend Favorite